(NBC) – A new kind of tick is causing an epidemic of Rocky Mountain spotted fever in Mexico, and it’s threatening to spread to the U.S., researchers said Wednesday.
Rocky Mountain spotted fever is already dangerous, and the new carrier is more likely to bite people than the ticks that usually spread it, the team of U.S. and Mexican researchers said.
As ticks in general become more common as the climate warms, they’re a bigger threat, they added.
“Rocky Mountain spotted fever, caused by the bacteria Rickettsia rickettsii, is responsible for more human deaths than any other tick-borne disease in North America,” the team wrote in the journal Emerging Infectious Diseases.
Rocky Mountain spotted fever was reported in 4,269 people in the U.S. in 2016, according to the Centers for Disease Control and Prevention. It can kill up to 10 percent of victims, depending on the outbreak.
It’s usually spread by the American dog tick and the closely related Rocky Mountain wood tick. But in recent years the bacterial infection has also been spread by the brown dog tick — a completely different species.
The researchers were investigating an epidemic of the infection that broke out in the border town of Mexicali starting in 2008. It’s already sickened at least 4,000 people, according to Mexican government estimates. Several hundred have died, and at least four people have died in the U.S. after crossing the border, according to this report and others.
“That’s a very big epidemic of a fatal disease,” said Dr. Janet Foley, an expert in the spread of animal-borne disease at the University of California Davis School of Veterinary Medicine. “There are likely thousands of cases.”
The infection is not always easy to diagnose in human blood. If people get a rash and other symptoms of Rocky Mountain spotted fever, the advice is to treat quickly with the antibiotic doxycycline. Other symptoms are similar to those caused by many infections and include fever, nausea and headache.
Working with a team at the Universidad Autónoma de Baja California in Mexicali, Foley and colleagues tested the blood of 16 patients to see if they could find a characteristic signature of the infection.
“I was absolutely startled,” Foley said in an interview. The people who had been sickened in Mexicali had a heavy load of the infectious agent in their blood — something that had not been seen in past outbreaks.